Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases

View More View Less
  • 1 Departments of Neurosurgery and Oncology, The Johns Hopkins School of Medicine, Baltimore, Maryland
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

Object. Image-guided stereotactic brain biopsy is associated with transient and permanent incidences of morbidity in 9 and 4.5% of patients, respectively. The goal of this study was to perform a critical analysis of risk factors predictive of an enhanced operative risk in frame-based and frameless stereotactic brain biopsy.

Methods. The authors reviewed the clinical and neuroimaging records of 270 patients who underwent consecutive frame-based and frameless image-guided stereotactic brain biopsies. The association between preoperative variables and biopsy-related morbidity was assessed by performing a multivariate logistic regression analysis.

Transient and permanent stereotactic biopsy-related morbidity was observed in 23 (9%) and 13 (5%) patients, respectively. A hematoma occurred at the biopsy site in 25 patients (9%); 10 patients (4%) were symptomatic. Diabetes mellitus (odds ratio [OR] 3.73, 95% confidence interval [CI] 1.37–10.17, p = 0.01), thalamic lesions (OR 4.06, 95% CI 1.63–10.11, p = 0.002), and basal ganglia lesions (OR 3.29, 95% CI 1.05–10.25, p = 0.04) were independent risk factors for morbidity. In diabetic patients, a serum level of glucose that was greater than 200 mg/dl on the day of biopsy had a 100% positive predictive value and a glucose level lower than 200 mg/dl on the same day had a 95% negative predictive value for biopsy-related morbidity. Pontine biopsy was not a risk factor for morbidity. Only two (4%) of 45 patients who had epilepsy before the biopsy experienced seizures postoperatively. The creation of more than one needle trajectory increased the incidence of neurological deficits from 17 to 44% when associated with the treatment of deep lesions (those in the basal ganglia or thalamus; p = 0.05), but was not associated with morbidity when associated with the treatment of cortex lesions.

Conclusions. Basal ganglia lesions, thalamic lesions, and patients with diabetes were independent risk factors for biopsy-associated morbidity. Hyperglycemia on the day of biopsy predicted morbidity in the diabetic population. Epilepsy did not predispose to biopsy-associated seizure. For deep-seated lesions, increasing the number of biopsy samples along an established track rather than performing a second trajectory may minimize the incidence of morbidity. Close perioperative observation of glucose levels may be warranted.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1.

    Apuzzo ML, , Chandrasoma PT, , Cohen D, , Zee CS, & Zelman V: Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 20:930937, 1987 Apuzzo ML, Chandrasoma PT, Cohen D, Zee CS, Zelman V: Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 20:930–937, 1987

    • Search Google Scholar
    • Export Citation
  • 2.

    Apuzzo ML, & Sabshin JK: Computed tomographic guidance stereotaxy in the management of intracranial mass lesions. Neurosurgery 12:277285, 1983 Apuzzo ML, Sabshin JK: Computed tomographic guidance stereotaxy in the management of intracranial mass lesions. Neurosurgery 12:277–285, 1983

    • Search Google Scholar
    • Export Citation
  • 3.

    Bernays RL, , Kollias SS, , Khan N, , Brandner S, , Meier S, & Yonekawa Y: Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg 97:354362, 2002 Bernays RL, Kollias SS, Khan N, Brandner S, Meier S, Yonekawa Y: Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg 97:354–362, 2002

    • Search Google Scholar
    • Export Citation
  • 4.

    Blaauw G, & Braakman R: Pitfalls in diagnostic stereotactic brain surgery. Acta Neurochir Suppl 42:161165, 1988 Blaauw G, Braakman R: Pitfalls in diagnostic stereotactic brain surgery. Acta Neurochir Suppl 42:161–165, 1988

    • Search Google Scholar
    • Export Citation
  • 5.

    Boethius J, , Collins VP, , Edner G, , Lewander R, & Zajicek J: Stereotactic biopsies and computer tomography in gliomas. Acta Neurochir 40:223232, 1978 Boethius J, Collins VP, Edner G, Lewander R, Zajicek J: Stereotactic biopsies and computer tomography in gliomas. Acta Neurochir 40:223–232, 1978

    • Search Google Scholar
    • Export Citation
  • 6.

    Bouvier G, , Couillard P, , Leger SL, , Lesage J, , Rotent F, & Beigne RA: Stereotactic biopsy of cerebral space-occupying lesions. Appl Neurophysiol 46:227230, 1983 Bouvier G, Couillard P, Leger SL, Lesage J, Rotent F, Beigne RA: Stereotactic biopsy of cerebral space-occupying lesions. Appl Neurophysiol 46:227–230, 1983

    • Search Google Scholar
    • Export Citation
  • 7.

    Boviatsis EJ, , Kouyialis AT, , Stranjalis G, , Korfias S, & Sakas DE: CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review. Neurol Sci 24:97102, 2003 Boviatsis EJ, Kouyialis AT, Stranjalis G, Korfias S, Sakas DE: CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review. Neurol Sci 24:97–102, 2003

    • Search Google Scholar
    • Export Citation
  • 8.

    Bruno A, , Levine SR, , Frankel MR, , Brott TG, , Lin Y, & Tilley BC, et al: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59:669674, 2002 Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al: Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59:669–674, 2002

    • Search Google Scholar
    • Export Citation
  • 9.

    Cherian L, , Hannay HJ, , Vagner G, , Goodman JC, , Contant CF, & Robertson CS: Hyperglycemia increases neurological damage and behavioral deficits from post-traumatic secondary ischemic insults. J Neurotrauma 15:307321, 1998 Cherian L, Hannay HJ, Vagner G, Goodman JC, Contant CF, Robertson CS: Hyperglycemia increases neurological damage and behavioral deficits from post-traumatic secondary ischemic insults. J Neurotrauma 15:307–321, 1998

    • Search Google Scholar
    • Export Citation
  • 10.

    Dorward NL, , Paleologos TS, , Alberti O, & Thomas DG: The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 16:110118, 2002 Dorward NL, Paleologos TS, Alberti O, Thomas DG: The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 16:110–118, 2002

    • Search Google Scholar
    • Export Citation
  • 11.

    Field M, , Witham TF, , Flickinger JC, , Kondziolka D, & Lunsford LD: Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 94:545551, 2001 Field M, Witham TF, Flickinger JC, Kondziolka D, Lunsford LD: Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 94:545–551, 2001

    • Search Google Scholar
    • Export Citation
  • 12.

    Friedman WA, , Sceats DJ Jr, , Nestok BR, & Ballinger WE Jr: The incidence of unexpected pathological findings in an image-guided biopsy series: a review of 100 consecutive cases. Neurosurgery 25:180185, 1989 Friedman WA, Sceats DJ Jr, Nestok BR, Ballinger WE Jr: The incidence of unexpected pathological findings in an image-guided biopsy series: a review of 100 consecutive cases. Neurosurgery 25:180–185, 1989

    • Search Google Scholar
    • Export Citation
  • 13.

    Gralla J, , Nimsky C, , Buchfelder M, , Fahlbusch R, & Ganslandt O: Frameless stereotactic brain biopsy procedures using the Stealth Station: indications, accuracy, and results. Zentralbl Neurochir 64:166170, 2003 Gralla J, Nimsky C, Buchfelder M, Fahlbusch R, Ganslandt O: Frameless stereotactic brain biopsy procedures using the Stealth Station: indications, accuracy, and results. Zentralbl Neurochir 64:166–170, 2003

    • Search Google Scholar
    • Export Citation
  • 14.

    Greene GM, , Hitchon PW, , Schelper RL, , Yuh W, & Dyste GN: Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg 71:494497, 1989 Greene GM, Hitchon PW, Schelper RL, Yuh W, Dyste GN: Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg 71:494–497, 1989

    • Search Google Scholar
    • Export Citation
  • 15.

    Hall WA: The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 82:17491755, 1998 Hall WA: The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 82:1749–1755, 1998

    • Search Google Scholar
    • Export Citation
  • 16.

    Heilbrun MP: Computed tomography-guided stereotactic systems. Clin Neurosurg 31:564581, 1983 Heilbrun MP: Computed tomography-guided stereotactic systems. Clin Neurosurg 31:564–581, 1983

    • Search Google Scholar
    • Export Citation
  • 17.

    Kawai N, , Keep RF, , Betz AL, & Nagao S: Hyperglycemia induces progressive changes in the cerebral microvasculature and bloodbrain barrier transport during focal cerebral ischemia. Acta Neurochir Suppl 71:219221, 1998 Kawai N, Keep RF, Betz AL, Nagao S: Hyperglycemia induces progressive changes in the cerebral microvasculature and bloodbrain barrier transport during focal cerebral ischemia. Acta Neurochir Suppl 71:219–221, 1998

    • Search Google Scholar
    • Export Citation
  • 18.

    Kelly PJ, , Earnest F IV, , Kall BA, , Goerss SJ, & Scheithauer B: Surgical options for patients with deep-seated brain tumors: computer-assisted stereotactic biopsy. Mayo Clin Proc 60:223229, 1985 Kelly PJ, Earnest F IV, Kall BA, Goerss SJ, Scheithauer B: Surgical options for patients with deep-seated brain tumors: computer-assisted stereotactic biopsy. Mayo Clin Proc 60:223–229, 1985

    • Search Google Scholar
    • Export Citation
  • 19.

    Kulkarni A, , Guha A, , Lozano A, & Bernstein M: Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 89:3135, 1998 Kulkarni A, Guha A, Lozano A, Bernstein M: Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 89:31–35, 1998

    • Search Google Scholar
    • Export Citation
  • 20.

    Lam AM, , Winn HR, , Cullen BF, & Sundling N: Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 75:545551, 1991 Lam AM, Winn HR, Cullen BF, Sundling N: Hyperglycemia and neurological outcome in patients with head injury. J Neurosurg 75:545–551, 1991

    • Search Google Scholar
    • Export Citation
  • 21.

    Lee T, , Kenny BG, , Hitchcock ER, , Teddy PJ, , Palividas H, & Harkness W, et al: Supratentorial masses: stereotactic or freehand biopsy? Br J Neurosurg 5:331338, 1991 Lee T, Kenny BG, Hitchcock ER, Teddy PJ, Palividas H, Harkness W, et al: Supratentorial masses: stereotactic or freehand biopsy? Br J Neurosurg 5:331–338, 1991

    • Search Google Scholar
    • Export Citation
  • 22.

    Lobato RD, , Rivas JJ, , Cabello A, & Roger R: Stereotactic biopsy of brain lesions visualized with computed tomography. Appl Neurophysiol 45:426430, 1982 Lobato RD, Rivas JJ, Cabello A, Roger R: Stereotactic biopsy of brain lesions visualized with computed tomography. Appl Neurophysiol 45:426–430, 1982

    • Search Google Scholar
    • Export Citation
  • 23.

    Mundinger F: CT stereotactic biopsy for optimizing the therapy of intracranial processes. Acta Neurochir Suppl 35:7074, 1985 Mundinger F: CT stereotactic biopsy for optimizing the therapy of intracranial processes. Acta Neurochir Suppl 35:70–74, 1985

    • Search Google Scholar
    • Export Citation
  • 24.

    Niizuma H, , Otsuki T, , Yonemitsu T, , Kitahara M, , Katakura R, & Suzuki J: Experiences with CT-guided stereotaxic biopsies in 121 cases. Acta Neurochir Suppl 42:157160, 1988 Niizuma H, Otsuki T, Yonemitsu T, Kitahara M, Katakura R, Suzuki J: Experiences with CT-guided stereotaxic biopsies in 121 cases. Acta Neurochir Suppl 42:157–160, 1988

    • Search Google Scholar
    • Export Citation
  • 25.

    Ostertag CB, , Mennel HD, & Kiessling M: Stereotactic biopsy of brain tumors. Surg Neurol 14:275283, 1980 Ostertag CB, Mennel HD, Kiessling M: Stereotactic biopsy of brain tumors. Surg Neurol 14:275–283, 1980

    • Search Google Scholar
    • Export Citation
  • 26.

    Ritter AM, , Robertson CS, , Goodman JC, , Contant CF, & Grossman RG: Evaluation of a carbohydrate-free diet for patients with severe head injury. J Neurotrauma 13:473485, 1996 Ritter AM, Robertson CS, Goodman JC, Contant CF, Grossman RG: Evaluation of a carbohydrate-free diet for patients with severe head injury. J Neurotrauma 13:473–485, 1996

    • Search Google Scholar
    • Export Citation
  • 27.

    Rovlias A, & Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46:335342, 2000 Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46:335–342, 2000

    • Search Google Scholar
    • Export Citation
  • 28.

    Sawin PD, , Hitchon PW, , Follett KA, & Torner JC: Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. Surg Neurol 49:640649, 1998 Sawin PD, Hitchon PW, Follett KA, Torner JC: Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. Surg Neurol 49:640–649, 1998

    • Search Google Scholar
    • Export Citation
  • 29.

    Wild AM, , Xuereb JH, , Marks PV, & Gleave JR: Computerized tomographic stereotaxy in the management of 200 consecutive intracranial mass lesions. Analysis of indications, benefits and outcome. Br J Neurosurg 4:407415, 1990 Wild AM, Xuereb JH, Marks PV, Gleave JR: Computerized tomographic stereotaxy in the management of 200 consecutive intracranial mass lesions. Analysis of indications, benefits and outcome. Br J Neurosurg 4:407–415, 1990

    • Search Google Scholar
    • Export Citation
  • 30.

    Yamada K, , Goto S, , Kochi M, & Ushio Y: Stereotactic biopsy for multifocal, diffuse, and deep-seated brain tumors using Leksell's system. J Clin Neurosci 11:263267, 2004 Yamada K, Goto S, Kochi M, Ushio Y: Stereotactic biopsy for multifocal, diffuse, and deep-seated brain tumors using Leksell's system. J Clin Neurosci 11:263–267, 2004

    • Search Google Scholar
    • Export Citation
  • 31.

    Yu X, , Liu Z, , Tian Z, , Li S, , Huang H, & Xiu B, et al: Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases. Stereotact Funct Neurosurg 75:103108, 2000 Yu X, Liu Z, Tian Z, Li S, Huang H, Xiu B, et al: Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases. Stereotact Funct Neurosurg 75:103–108, 2000

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 1118 356 12
Full Text Views 324 35 5
PDF Downloads 206 30 4
EPUB Downloads 0 0 0